#EUfunded GAPVAC researchers have conducted a pioneering human trial of personalised cancer vaccines to pave the way for new treatments for illnesses such as the aggressive brain cancer #glioblastoma
— PRAATNEDERLANDS Ⓥ (@praatnederlands) February 28, 2019
➡️https://t.co/eojsAleRbm#RareDiseaseDay #EUHealth… https://t.co/aw6uBdoIEg
from Twitter https://twitter.com/praatnederlands #euiapress #euinternationalacademy more #EUIAOJ at https://ift.tt/2GeCjyM
Geen opmerkingen:
Een reactie posten